Background
Pretreating renal formulas with medications to lower the potassium and phosphorus content is common in clinical practice; however, the effect of this treatment on other nutrients is relatively unstudied. We examine whether nutrient composition is affected by pretreating renal formulas with sodium polystyrene sulfonate (SPS) suspension and sevelamer carbonate.
Methods
Fixed medication doses and treatment times were utilized to determine changes in the nutrient composition of Suplena® and Similac® PM 60/40. The effect of simultaneously adding both medications (co-administration) to the formula on the nutrient composition of Suplena® was also evaluated.
Results
Pretreatment of Suplena® with SPS reduced the concentrations of calcium (11–38 %), copper (3–11 %), manganese (3–16 %), phosphorus (0–7 %), potassium (6–34 %), and zinc (5–20 %) and increased those of iron (9–34 %), sodium (89–260 %), and sulfur (19–45 %) and the pH (0.20–0.50 units). Pretreatment of Similac® PM 60/40 with SPS reduced the concentrations of calcium (8–29 %), copper (5–19 %), magnesium (3–26 %), and potassium (33–63 %) and increased those of iron (13–87 %) and sodium (86–247 %) and the pH (0.40–0.81 units). Pretreatment of both formulas with the SPS suspension led to significant increases in the aluminum concentration in both formulas (507–3957 %). No differences in potassium concentration were observed between treatment times. Unexpectedly, the levels of neither phosphorus nor potassium were effectively reduced in Suplena® pretreated with sevelamer carbonate alone or when co-administered with SPS.
Conclusions
Pretreating formula with medications alters nutrients other than the intended target(s). Future studies should be aimed at predicting the loss of these nutrients or identifying alternative methods for managing serum potassium and phosphorus levels in formula-fed infants. The safety of pretreating formula with SPS suspension should also be examined.
Background
Anthropometric z‐scores used commonly for diagnosis and determining degree of malnutrition, specifically body mass index (BMIz), weight‐for‐length (WLz), and mid‐upper arm circumference (MUACz), are not wholly concordant, yet the proposed thresholds for classification are identical. This study was designed to critically examine MUACz thresholds and their ability to correctly classify nutrition status.
Methods
This was a 2‐year, prospective single‐center study of children ≤18 years seen by registered dietitians within a large pediatric institution. The sensitivity, specificity, and predictive performance of the malnutrition classification thresholds were estimated against clinician‐based classification.
Results
Sixty‐one dietitians enrolled 10,401 patients with distributions of z‐scores for weight (−0.5 ± 1.9), length (−0.8 ± 1.6), BMI or WL (−0.1 ± 1.8), and MUAC (−0.4 ± 1.5), suggesting participants were smaller and shorter than the reference U.S. population. Distributions of MUACz were broad and overlapped between nutrition classification groups, an observation that extended to BMIz and WLz as well. Consequently, existing thresholds do not accurately classify 100% of children. Misclassification rates increase, with increasing severity ranging from 8% in children with no malnutrition to 71% in children with severe malnutrition. Algorithm‐ and manually‐based refinement of thresholds result in mixed improvements and can be explored by the reader with the associated supplement.
Conclusion
The sensitivity of proposed MUACz thresholds systematically decreases with increasing severity of malnutrition and will require optimization if we aim to limit the number of children at risk of misclassification. Indicators for overnutrition remain to be addressed but are explored herein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.